Treatment for T1 colorectal cancers substratified by site and size: “horses for courses”
BackgroundOwing to advances in diagnostic technology, the diagnosis of T1 colorectal cancers (CRCs) continues to increase. However, the optimal management of T1 CRCs in the Western Hemisphere remains unclear due to limited population-based data directly comparing the efficacy of endoscopic therapy (...
Main Authors: | Kexin Shi, Zhen Yang, Kaiming Leng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1230844/full |
Similar Items
-
Clinical significance of the histopathological metastatic largest lymph node size in colorectal cancer patients
by: Sinan Omeroglu, et al.
Published: (2023-03-01) -
An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
by: Zheng Hua Piao, et al.
Published: (2023-10-01) -
Endoscopic Submucosal Dissection for Early Gastric Cancers with Uncommon Histology
by: Gwang Ha Kim
Published: (2016-09-01) -
Analysis of risk factors of lymph node metastasis and comparison of endoscopic resection methods in rectal neuroendocrine neoplasm
by: ZHENG Xiuli, YAO Zhiyuan, WU Mingli, ER Limian, LI Shengmian
Published: (2022-09-01) -
Lymph node evaluation and survival after resection of colorectal cancer
by: Lutfi Soylu, et al.
Published: (2017-06-01)